The Experts below are selected from a list of 45483 Experts worldwide ranked by ideXlab platform
Shinichi Uchida - One of the best experts on this subject based on the ideXlab platform.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db micenovelty and significance
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both Spak T243A/+ and Osr1 T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db mice
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both SpakT243A/+ and Osr1T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
Hidenori Nishida - One of the best experts on this subject based on the ideXlab platform.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db micenovelty and significance
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both Spak T243A/+ and Osr1 T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db mice
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both SpakT243A/+ and Osr1T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
Dario R. Alessi - One of the best experts on this subject based on the ideXlab platform.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db micenovelty and significance
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both Spak T243A/+ and Osr1 T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db mice
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both SpakT243A/+ and Osr1T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
Sei Sasaki - One of the best experts on this subject based on the ideXlab platform.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db micenovelty and significance
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both Spak T243A/+ and Osr1 T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db mice
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both SpakT243A/+ and Osr1T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
Motoko Chiga - One of the best experts on this subject based on the ideXlab platform.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db micenovelty and significance
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both Spak T243A/+ and Osr1 T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.
-
Phosphatidylinositol 3 Kinase akt signaling pathway activates the wnk osr1 spak ncc phosphorylation cascade in hyperinsulinemic db db mice
Hypertension, 2012Co-Authors: Hidenori Nishida, Motoko Chiga, Naohiro Nomura, Eisei Sohara, Dario R. Alessi, Tatemitsu Rai, Sei Sasaki, Shinichi UchidaAbstract:Metabolic syndrome patients have insulin resistance, which causes hyperinsulinemia, which in turn causes aberrant increased renal sodium reabsorption. The precise mechanisms underlying this greater salt sensitivity of hyperinsulinemic patients remain unclear. Abnormal activation of the recently identified with-no-lysine Kinase (WNK)-oxidative stress-responsive Kinase 1 (OSR1)/STE20/SPS1-related proline/alanine-rich Kinase (SPAK)-NaCl cotransporter (NCC) phosphorylation cascade results in the salt-sensitive hypertension of pseudohypoaldosteronism type II. Here, we report a study of renal WNK-OSR1/SPAK-NCC cascade activation in the db/db mouse model of hyperinsulinemic metabolic syndrome. Thiazide sensitivity was increased, suggesting greater activity of NCC in db/db mice. In fact, increased phosphorylation of OSR1/SPAK and NCC was observed. In both SpakT243A/+ and Osr1T185A/+ knock-in db/db mice, which carry mutations that disrupt the signal from WNK Kinases, increased phosphorylation of NCC and elevated blood pressure were completely corrected, indicating that phosphorylation of SPAK and OSR1 by WNK Kinases is required for the increased activation and phosphorylation of NCC in this model. Renal phosphorylated Akt was increased in db/db mice, suggesting that increased NCC phosphorylation is regulated by the Phosphatidylinositol 3-Kinase/Akt signaling cascade in the kidney in response to hyperinsulinemia. A Phosphatidylinositol 3-Kinase inhibitor (NVP-BEZ235) corrected the increased OSR1/SPAK-NCC phosphorylation. Another more specific Phosphatidylinositol 3-Kinase inhibitor (GDC-0941) and an Akt inhibitor (MK-2206) also inhibited increased NCC phosphorylation. These results indicate that the Phosphatidylinositol 3-Kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in db/db mice. This mechanism may play a role in the pathogenesis of salt-sensitive hypertension in human hyperinsulinemic conditions, such as the metabolic syndrome.